LSECtin on tumor-associated macrophages enhances breast cancer stemness via interaction with its receptor BTN3A3

Di Liu,Qian Lu,Xing Wang,Jun Wang,Ning Lu,Zefei Jiang,Xiaopeng Hao,Jianbin Li,Jing Liu,Pengbo Cao,Guilin Peng,Yuandong Tao,Dianyuan Zhao,Fuchu He,Li Tang
DOI: https://doi.org/10.1038/s41422-019-0155-6
IF: 44.1
2019-01-01
Cell Research
Abstract:Macrophages have been suggested to contribute to constructing a cancer stem cell (CSC) niche. However, whether and how macrophages regulate the activity of CSCs through juxtacrine signaling are poorly understood. Here we report LSECtin, a transmembrane protein highly expressed on tumor-associated macrophages (TAMs), enhances stemness of breast cancer cells (BCCs). We identified BTN3A3, a B7 family member with previously unknown functions as the receptor for LSECtin on BCCs responsible for stemness-promoting effect of LSECtin. In mice bearing human tumor xenografts, either macrophage-specific ablation of LSECtin or silencing of BTN3A3 in BCCs decreased CSC frequency and tumor growth. Admixture of LSECtin-positive macrophages increased the tumorigenic activity of BCCs dependent on BTN3A3. Disruption of the LSECtin-BTN3A3 axis with BTN3A3-Fc or anti-BTN3A3 mAb has a therapeutic effect on breast cancer. These findings define a juxtacrine signaling mechanism by which TAMs promote cancer stemness. Targeting this axis in the CSC niche may provide potential therapies to breast cancer.
What problem does this paper attempt to address?